A Pilot Longitudinal Follow-Up Study of Tau Burden in The Brain of Subjects With Alzheimer's Disease Who Previously Participated in Study BP29409 Using [18F]RO6958948 Positron Emission Tomography
Phase of Trial: Phase I
Latest Information Update: 27 Jul 2017
At a glance
- Drugs RO 6958948 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- Sponsors Roche
- 20 Jul 2017 Status changed from recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 01 Sep 2016 Status changed from not yet recruiting to recruiting.